These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7496731)

  • 21. Development of an azopolymer based colonic release capsule for delivering proteins/macromolecules.
    Cheng CL; Gehrke SH; Ritschel WA
    Methods Find Exp Clin Pharmacol; 1994 May; 16(4):271-8. PubMed ID: 8051987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the properties of ethylcellulose-cellulose triacetate microcapsules containing theophylline prepared by different microencapsulation techniques.
    Wu JC; Jean WJ; Chen H
    J Microencapsul; 1994; 11(5):507-18. PubMed ID: 7815268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and evaluation of pulsatile drug delivery system using novel polymer.
    Tekade AR; Gattani SG
    Pharm Dev Technol; 2009; 14(4):380-7. PubMed ID: 19235549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Injection Molded Capsules for Colon Delivery Combining Time-Controlled and Enzyme-Triggered Approaches.
    Federica C; Alice M; Saliha M; Marco U; Anastasia F; Alessandra M; Lucia Z; Christel N; Florence S; Juergen S; Andrea G
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32168895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Process and formulation variables affecting the performance of a rupturable capsule-based drug delivery system with pulsatile drug release.
    Dashevsky A; Bussemer T; Mohamad A; Bodmeier R
    Drug Dev Ind Pharm; 2004 Feb; 30(2):171-9. PubMed ID: 15089051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3D printed capsules for quantitative regional absorption studies in the GI tract.
    Smith D; Kapoor Y; Hermans A; Nofsinger R; Kesisoglou F; Gustafson TP; Procopio A
    Int J Pharm; 2018 Oct; 550(1-2):418-428. PubMed ID: 30172750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osmotic capsules: A universal oral, controlled-release drug delivery dosage form.
    Waterman KC; Goeken GS; Konagurthu S; Likar MD; MacDonald BC; Mahajan N; Swaminathan V
    J Control Release; 2011 Jun; 152(2):264-9. PubMed ID: 21315121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a dosage form for accelerated release.
    Waldner C; Friedl HE; Dünnhaupt S; Köllner S; Leonaviciute G; Bernkop-Schnürch A
    Int J Pharm; 2014 Aug; 471(1-2):189-96. PubMed ID: 24834878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Injection-molded capsular device for oral pulsatile release: development of a novel mold.
    Zema L; Loreti G; Macchi E; Foppoli A; Maroni A; Gazzaniga A
    J Pharm Sci; 2013 Feb; 102(2):489-99. PubMed ID: 23161022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of colonic absorbability of drugs in dogs using a novel colon-targeted delivery capsule (CTDC).
    Ishibashi T; Ikegami K; Kubo H; Kobayashi M; Mizobe M; Yoshino H
    J Control Release; 1999 Jun; 59(3):361-76. PubMed ID: 10332066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time and pH dependent colon specific, pulsatile delivery of theophylline for nocturnal asthma.
    Mastiholimath VS; Dandagi PM; Jain SS; Gadad AP; Kulkarni AR
    Int J Pharm; 2007 Jan; 328(1):49-56. PubMed ID: 16942847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of in vitro release tests for the prediction of the in vivo behavior and the development of flucytosine controlled-release capsules.
    Bonny JD; Kyowa M
    J Pharm Sci; 1995 May; 84(5):619-23. PubMed ID: 7658354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro performance of floating sustained-release capsule of verapamil.
    Chen GL; Hao WH
    Drug Dev Ind Pharm; 1998 Nov; 24(11):1067-72. PubMed ID: 9876561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo drug release behavior in dogs from a new colon-targeted delivery system.
    Ishibashi T; Hatano H; Kobayashi M; Mizobe M; Yoshino H
    J Control Release; 1999 Jan; 57(1):45-53. PubMed ID: 9863038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo evaluation of a novel capsule for colon-specific drug delivery.
    Han M; Fang QL; Zhan HW; Luo T; Liang WQ; Gao JQ
    J Pharm Sci; 2009 Aug; 98(8):2626-35. PubMed ID: 19067397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulsatile drug release from an insoluble capsule body controlled by an erodible plug.
    Krögel I; Bodmeier R
    Pharm Res; 1998 Mar; 15(3):474-81. PubMed ID: 9563080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of the atomization time on the properties of ethylcellulose microcapsules of isoniazid prepared by a fluidized bed.
    Senjković R; Jalsenjak I
    J Microencapsul; 1984; 1(3):241-7. PubMed ID: 6336528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experiment on formulation and drug release behavior of porosity asymmetric membrane capsules in vitro.
    Fu HX; Li H; Zhang FZ; Zhao YZ; Wan CW; Chen MT; Jia XC; Yan L; Sun CC; Xu YY
    Drug Dev Ind Pharm; 2012 Jun; 38(6):670-8. PubMed ID: 22469006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a novel drug release system, time-controlled explosion system (TES). I. Concept and design.
    Ueda S; Hata T; Asakura S; Yamaguchi H; Kotani M; Ueda Y
    J Drug Target; 1994; 2(1):35-44. PubMed ID: 8069582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osmotically controlled pulsatile release capsule of montelukast sodium for chronotherapy: statistical optimization, in vitro and in vivo evaluation.
    Ranjan OP; Nayak UY; Reddy MS; Dengale SJ; Musmade PB; Udupa N
    Drug Deliv; 2014 Nov; 21(7):509-18. PubMed ID: 24215165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.